Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2023

May 12, 2023

BUY
$32.86 - $55.7 $213,590 - $362,050
6,500 New
6,500 $248,000
Q2 2020

Aug 14, 2020

BUY
$16.25 - $26.81 $487,500 - $804,300
30,000 New
30,000 $804,000
Q1 2020

May 14, 2020

SELL
$13.9 - $21.83 $145,950 - $229,214
-10,500 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$16.68 - $18.41 $175,140 - $193,305
10,500 New
10,500 $191,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.62B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.